Ind-Swift Laboratories share news and announcements
NSE: INDSWFTLABBSE: 532305Pharmaceuticals & BiotechnologySmall Cap
Last close ₹327.45down ₹17.90 (5.18%)BSE ₹327.80
Share price at the NSE close on 23 Oct 2026. Previous close ₹345.35.
52-week range of traded prices to 23 Oct 2026
₹87.15Low, 31 Dec 2025₹424.75High, 30 Sep 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,848 Cr1,404th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 49.7
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 41.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 2.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 4.5%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹11 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 2.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 6,58,24852.8% delivered
Ind-Swift Laboratories share news and announcements
907 announcements, routine notices left out, newest first. Page 16 of 19.
Mar 2013
Feb 2013
12 Feb · Board meeting
Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on February 12, 2013 to consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended December 31, 2012. The Company has now informed that due to some unavoidable circumstances, the aforesaid Board Meeting has been postponed and will now be held on February 13, 2013.
Jan 2013
30 Jan · Board meeting
To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended December 31, 2012.3 Jan · Updates
Proposal of the Company for restructuring of its Debt has been approved by the Empowered Group of Corporate Debt Restructuring (CDR) Cell communicated vide its Letter of Approval (LOA) dated November 09, 2012. Pursuant to the term and conditions of LOA, the Master Restructuring Agreement (MRA) has been executed between the Company and the Lenders on December 27, 2012. The cut off date for the CDR Package shall be July 01, 2012. The CDR Package envisages reduction in rate of interest; deferment of payment of interest and principal amount of working capital facilities and term loans after a moratorium of 21 months from the cut off date.
Nov 2012
8 Nov · Updates
(1) Shri S.P. Sharma has resigned from the Directorship of the Company; (2) Shri Atul Saxena (Vice President, IFCI LTD.) has been appointed as Nominee Director on the Board of the Company; (3) Shri T.S. Bhattacharya has been appointed as an Independent Director on the Board of the Company.
Oct 2012
22 Oct · Board meeting
To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended September 30, 2012.
Sep 2012
4 Sep · News Verification
News Verification : The media had reports that Piramal Healthcare Limited is in talks with Ind-Swift Laboratories Limited to acquire its contract research and manufacturing business. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ind-Swift Laboratories Limited has vide its letter inter-alia stated, "The company's management hereby clarifies that there is no discussion in progress for selling the company. However, we are looking for investors as per our earlier disclosed plans for which, enabling resolutions were approved by the shareholders in the last AGM held in 2011. Company will inform the exchanges and public accordingly as and when there is any definitive agreement."
Aug 2012
28 Aug · Meeting
Register of Members of the Company shall remain closed from September 25, 2012 to September 29, 2012 (both days inclusive) . Further, the Annual General Meeting of the shareholders of the Company to be held on September 29, 2012.2 Aug · Board meeting
To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended June 30, 2012.
Jul 2012
16 Jul · Board meeting
In view of the adverse market conditions and debt burden, the Board of Directors of the Company at its meeting held on July 14, 2012, has accorded its consent for making reference to the Corporate Debt Restructuring (CDR) Cell through State Bank of India for financial restructuring of the debts of the Company under CDR Mechanism formulated by Reserve Bank of India.16 Jul · Updates
In view of the adverse market conditions and debt burden, the Board of Directors of the Company at its meeting held on July 14, 2012, has accorded its consent for making reference to the Corporate Debt Restructuring (CDR) Cell through State Bank of India for financial restructuring of the debts of the Company under CDR Mechanism formulated by Reserve Bank of India.
May 2012
31 May · Board meeting
Board of Directors of the Company at its meeting held on May 30, 2012, inter alia, have approved the following :(1) The Board of Directors have decided to plough back the profit for this year for future corporate needs, so has not declared any dividend on Equity Shares of the Company. 2) The Board has allotted 10,000 equity shares to the Independent Directors of the Company under Employee Stock option Scheme, 2006, at a price of Rs. 27/- per share.17 May · Board meeting
To transact inter-alia among other items the following business: (1) To adopt Annual Audited Accounts for the financial year ended March 31, 2012; (2) To consider declaration of dividend if any, approved by the Board on the equity shares of the Company; (3) Allotment of equity shares under Employee Stock Option Plan (ESOP).2 May · Results
Company has decided to adopt the audited financial results for the year ending 2011-12 on or before May 30, 2012 instead of adopting Unaudited Quarterly Results for the quarter ended March 31, 2012.
Apr 2012
19 Apr · Business
Board of Directors in its meeting held on April 19, 2012 approved the allotment of 13,15,000 equity shares as under :(1) 13,15,000 equity shares allotted to Promoters Group Companies upon conversion of 13,15,000 Zero Coupon Optionally Convertible Warrants (2010 Series) at a price of Rs. 82.50/- per share.12 Apr · Board meeting
To consider and approve interalia, among other items, allotment of shares upon part conversion of Zero Coupon Convertible Warrants (SERIES 2010) into equity shares of the holders of the warrants.
Feb 2012
24 Feb · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2011 A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2012
30 Jan · Board meeting
To consider, interalia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended December 31, 2011.16 Jan · Board meeting
Board of Directors in its meeting held on January 16, 2012 approved the allotment of 15,61,000 equity shares as under :- (1) 15,61,000 equity shares allotted to Promoters Group Companies upon conversion of 15,61,000 Zero Coupon Optionally Convertible Warrants (2010 Series) at a price of Rs. 82.50/- per share.11 Jan · Board meeting
To consider and approve interalia, among other items, allotment of shares upon part conversion of Zero Coupon Convertible Warrants (SERIES 2010) into equity shares of the holders of the warrants.
Dec 2011
Nov 2011
Oct 2011
25 Oct · Board meeting
To consider inter-alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the second quarter ended September 30, 2011.
Sep 2011
26 Sep · Meeting
Shareholders of the Company in its Annual General Meeting held on September 26, 2011 have inter-alia, among other items approved the following : (1) Adoption of Audited Financial Results for the year 2010-11; (2) Declaration of Dividend of Rs. 1/- per share of face value of Rs. 10/- each for the financial year 2010-11; (3) To raise funds upto Rs. 500 Crores through issue of GDRs/FCCBs/Convertible Bonds.2 Sep · Meeting
Register of Members of the Company shall remain closed from September 22, 2011 to September 26, 2011 (both days inclusive) for the purpose of Annual General Meeting and payment of Dividend. Further, the Annual General Meeting of the shareholders of the Company is scheduled to be held on September 26, 2011.2 Sep · Board meeting
Board of Directors have in its meeting held on August 31, 2011 approved inter-alia the following: (1) The Board has allotted 19,39,000 equity shares allotted to Promoters Group upon conversion of 19,39,000 Zero Coupon Warrants (Series 2010) at a price of Rs.82.50 per share. (2) To raise funds upto Rs. 500 crores through GDR/FCCB/QIP or any other route. (3) The Board has deferred the fresh allotments of Convertible Warrants.
Aug 2011
24 Aug · Board meeting
To consider inter-alia among other items the following matter :- (1) Conversion of Zero Coupon Convertible Warrants into Shares; (2) To consider Fresh Allotments of Convertible Warrants.
Jul 2011
21 Jul · Board meeting
To consider inter alia among other items, the Quarterly Unaudited Financial Results (Provisional) for the quarter ended June 30, 2011.
May 2011
30 May · Updates
The Income Tax Authorities on Thursday, May 26, 2011, conducted search on Ind-Swift Laboratories Ltd. The search got concluded on May 27, 2011 early hours. During the search, Company voluntarily disclosed an income of Rs.12,73,41,000/- relating to FY 2011-12. The Company and its team fully co-operated with the authorities.26 May · Business
Board of Directors of the Company at its meeting held on May 25, 2011 has allotted 222400 equity shares to the employees of the Company under Employees Stock Option Scheme 2006 at a price of Rs.27/- per share.